OpenURL Connection Search

Select item for more details and to access through your institution.

Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case–control study.
Published in:
Neuro-Oncology Practice, 2024, v. 11, n. 4, p. 475, doi. 10.1093/nop/npae029
By:
- Gregory, Timothy A;
- Knight, Stephanie R;
- Aaroe, Ashley E;
- Highsmith, Kaitlin N;
- Janatpour, Zachary C;
- O'Brien, Barbara J;
- Majd, Nazanin K;
- Loghin, Monica E;
- Patel, Chirag B;
- Weathers, Shiao-Pei;
- Puduvalli, Vinay K;
- Kamiya-Matsuoka, Carlos
Publication type:
Article
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
Published in:
Neuro-Oncology, 2015, v. 17, n. 2, p. 266, doi. 10.1093/neuonc/nou155
By:
- Penas-Prado, Marta;
- R. Hess, Kenneth;
- Fisch, Michael J.;
- Lagrone, Lore W.;
- Groves, Morris D.;
- Levin, Victor A.;
- De Groot, John F.;
- Puduvalli, Vinay K.;
- Colman, Howard;
- Volas-Redd, Gena;
- Giglio, Pierre;
- Conrad, Charles A.;
- Salacz, Michael E.;
- Floyd, Justin D.;
- Loghin, Monica E.;
- Hsu, Sigmund H.;
- Gonzalez, Javier;
- Chang, Eric L.;
- Woo, Shiao Y.;
- Mahajan, Anita
Publication type:
Article
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
Published in:
2019
By:
- Maraka, Stefania;
- Groves, Morris D.;
- Mammoser, Aaron G.;
- Melguizo‐Gavilanes, Isaac;
- Conrad, Charles A.;
- Tremont‐Lukats, Ivo W.;
- Loghin, Monica E.;
- O'Brien, Barbara J.;
- Puduvalli, Vinay K.;
- Sulman, Erik P.;
- Hess, Kenneth R.;
- Aldape, Kenneth D.;
- Gilbert, Mark R.;
- de Groot, John F.;
- Alfred Yung, W.K.;
- Penas‐Prado, Marta;
- Melguizo-Gavilanes, Isaac;
- Tremont-Lukats, Ivo W;
- Penas-Prado, Marta
Publication type:
journal article
Toxicity in the era of immune checkpoint inhibitor therapy.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1447021
By:
- Keam, Synat;
- Turner, Naimah;
- Kugeratski, Fernanda G.;
- Rico, Rene;
- Colunga-Minutti, Jocelynn;
- Poojary, Rayansh;
- Alekseev, Sayan;
- Patel, Anisha B.;
- Li, Yuanteng Jeff;
- Sheshadri, Ajay;
- Loghin, Monica E.;
- Woodman, Karin;
- Aaroe, Ashley E.;
- Hamidi, Sarah;
- Iyer, Priyanka Chandrasekhar;
- Palaskas, Nicolas L.;
- Yinghong Wang;
- Nurieva, Roza
Publication type:
Article

Found: 4

Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case–control study.

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.

Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.

Toxicity in the era of immune checkpoint inhibitor therapy.